NCT04899687View on ClinicalTrials.gov

Study of Dextromethorphan in OCD and Related Disorders

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 20, 2022

Primary Completion Date

April 1, 2026

Study Completion Date

December 1, 2026

Conditions
Obsessive-Compulsive DisorderIllness Anxiety DisorderBody Dysmorphic DisordersSomatic Symptom Disorder
Interventions
DRUG

Fluoxetine

Fluoxetine 20mg (or previously prescribed dose) will be taken once daily by mouth for 8 weeks

DRUG

Dextromethorphan

Dextromethorphan, an over-the-counter cough suppressant, will be taken by mouth twice daily for four weeks of the study, starting at 15mg per dose, and increasing weekly as tolerated to a maximum of 60mg per dose.

Trial Locations (1)

94304

RECRUITING

Stanford University, Stanford

All Listed Sponsors
collaborator

Avy L. & Roberta L. Miller Foundation

UNKNOWN

lead

Stanford University

OTHER